3E0R302
3E0R302 — Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduce of High dose IL-2 into Spinal Canal, Perc Approach
How 3E0R302 is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- RBody partThe specific site
- 3ApproachHow the site was reached
- 0DeviceWhat was left in place, if anything
- 2QualifierA further distinction where one applies
Codes near 3E0R302
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E0Q3TZIntroduction of Destructive Agent into Cranial Cavity and Brain, Percutaneous Approach
- 3E0Q704Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Via Natural or Artificial Opening
- 3E0Q705Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening
- 3E0Q70MIntroduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening
- 3E0Q7SFIntroduction of Other Gas into Cranial Cavity and Brain, Via Natural or Artificial Opening
- 3E0R0AZIntroduction of Embryonic Stem Cells into Spinal Canal, Open Approach
- 3E0R0E0Introduction of Autologous Somatic Stem Cells into Spinal Canal, Open Approach
- 3E0R0E1Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Open Approach
- 3E0R302Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
- 3E0R303Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
- 3E0R304Introduction of Liquid Brachytherapy Radioisotope into Spinal Canal, Percutaneous Approach
- 3E0R305Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach
- 3E0R30MIntroduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach
- 3E0R328Introduction of Oxazolidinones into Spinal Canal, Percutaneous Approach
- 3E0R329Introduction of Other Anti-infective into Spinal Canal, Percutaneous Approach
- 3E0R33ZIntroduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach
- 3E0R36ZIntroduction of Nutritional Substance into Spinal Canal, Percutaneous Approach